You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. GRAPHITE BIO INC

Graphite Bio Inc

XNAS: GRPH

Download real time

Watchlist

Portfolio

Share
2,911.8

Market Cap

High in industry
-23.4

PE TTM

Negative PE TTM
1

PEG TTM

PEG TTM is less than 1
14.2

Price to Book

High in industry
0.4

Beta 1Year

Very Low volatility


Insider Trading disclosures for Graphite Bio Inc

The latest disclosure was made by Joseph Jimenez in Graphite Bio Inc where a trade of 20,000 Stock Option (right to buy) done was reported to US exchanges on July 19, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Joseph Jimenez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 20,000 20,000 - - Stock Option (right to buy)
Kristen M. Hege Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 20,000 20,000 - - Stock Option (right to buy)
Matthew Porteus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 20,000 20,000 - - Stock Option (right to buy)
Abraham Bassan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 20,000 20,000 - - Stock Option (right to buy)
Carlo Rizzuto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 20,000 20,000 - - Stock Option (right to buy)
Joanne Viney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 20,000 20,000 - - Stock Option (right to buy)
Jerel Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 20,000 20,000 - - Stock Option (right to buy)
Smital Shah Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 20,000 20,000 - - Stock Option (right to buy)
Perry A. Karsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 20,000 20,000 - - Stock Option (right to buy)
Alethia Young Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2023 220,000 220,000 - - Stock Option (right to buy)
Joshua Lehrer-Graiwer Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2023 600,000 600,000 - - Stock Option (right to buy)
Matthew Porteus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 20,000 20,000 - - Stock Option (right to buy)
Abraham Bassan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 20,000 20,000 - - Stock Option (right to buy)
Carlo Rizzuto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 20,000 20,000 - - Stock Option (right to buy)
Joanne Viney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 20,000 20,000 - - Stock Option (right to buy)
Jerel Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 20,000 20,000 - - Stock Option (right to buy)
Smital Shah Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 20,000 20,000 - - Stock Option (right to buy)
Perry A. Karsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 20,000 20,000 - - Stock Option (right to buy)
Kristen M. Hege Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 20,000 20,000 - - Stock Option (right to buy)
Joseph Jimenez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 20,000 20,000 - - Stock Option (right to buy)
Philip P. Gutry CHIEF BUSINESS OFFICER Purchase of securities on an exchange or from another person at price $ 4.01 per share. 11 Apr 2022 5,000 299,941 - 4.0 20,050 Common Stock
Alethia Young Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2022 350,000 350,000 - - Stock Option (right to buy)
Jerel Davis Director, Ten Percent Owner 29 Jun 2021 3,715,415 0 - - Series B Preferred Stock
Jerel Davis Director, Ten Percent Owner 29 Jun 2021 30,019,945 0 - - Series A Preferred Stock
Jerel Davis Director, Ten Percent Owner 29 Jun 2021 1,527,719 1,527,719 - - Common Stock
Jerel Davis Director, Ten Percent Owner 29 Jun 2021 12,343,727 14,708,398 - - Common Stock
Jerel Davis Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 17.00 per share. 29 Jun 2021 180,000 1,707,719 - 17 3,060,000 Common Stock
Carlo Rizzuto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Abraham Bassan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Smital Shah Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2021 93,585 93,585 - - Stock Option (right to buy)
Smital Shah Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 15 Apr 2021 5,882 5,882 - 17 99,994 Common Stock
Jerel Davis Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 40,000 40,000 - - Stock Option (right to buy)
Jerel Davis Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 10,000,000 30,019,945 - - Series A Preferred Stock
Jerel Davis Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 3,715,415 3,715,415 - - Series B Preferred Stock
Katherine Vega Stultz CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 99,753 99,753 - - Stock Option (right to buy)
Katherine Vega Stultz CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 209,846 209,846 - - Stock Option (right to buy)
Perry A. Karsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 19,763 19,763 - - Series B Preferred Stock
Perry A. Karsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 74,794 74,794 - - Stock Option (right to buy)
Perry A. Karsen Director 13 Jan 2021 8,126 164,034 - - Common Stock
Perry A. Karsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 18,698 18,698 - - Stock Option (right to buy)
Joseph Jimenez Director 13 Jan 2021 19,763 0 - - Series B Preferred Stock
Joseph Jimenez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 12,469 12,469 - - Stock Option (right to buy)
Joseph Jimenez Director 13 Jan 2021 8,126 161,941 - - Common Stock
Joseph Jimenez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 49,876 49,876 - - Stock Option (right to buy)
Joseph Jimenez Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2021 49,876 0 - - Stock Option (right to buy)
Joseph Jimenez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 19,763 19,763 - - Series B Preferred Stock
Joseph Jimenez Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 13 Jan 2021 49,876 153,815 - 0.3 14,963 Common Stock
Joshua Lehrer-Graiwer Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2021 374,013 0 - - Stock Option (right to buy)
Philip P. Gutry CHIEF BUSINESS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 162,410 162,410 - - Stock Option (right to buy)
Philip P. Gutry CHIEF BUSINESS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 69,604 69,604 - - Stock Option (right to buy)
Philip P. Gutry CHIEF BUSINESS OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2021 3,383 159,027 - - Stock Option (right to buy)
Philip P. Gutry CHIEF BUSINESS OFFICER 13 Jan 2021 19,763 0 - - Series B Preferred Stock
Philip P. Gutry CHIEF BUSINESS OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.11 per share. 13 Jan 2021 3,383 285,345 - 6.1 20,670 Common Stock
Philip P. Gutry CHIEF BUSINESS OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 13 Jan 2021 91,406 281,962 - 0.3 27,422 Common Stock
Philip P. Gutry CHIEF BUSINESS OFFICER 13 Jan 2021 8,126 293,471 - - Common Stock
Philip P. Gutry CHIEF BUSINESS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 91,406 91,406 - - Stock Option (right to buy)
Philip P. Gutry CHIEF BUSINESS OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2021 91,406 0 - - Stock Option (right to buy)
Philip P. Gutry CHIEF BUSINESS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 19,763 19,763 - - Series B Preferred Stock
Joshua Lehrer-Graiwer Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 374,013 374,013 - - Stock Option (right to buy)
Perry A. Karsen Director 13 Jan 2021 19,763 0 - - Series B Preferred Stock
Joshua Lehrer-Graiwer Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 795,196 795,196 - - Stock Option (right to buy)
Joshua Lehrer-Graiwer Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 340,798 340,798 - - Stock Option (right to buy)
Joshua Lehrer-Graiwer Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 19,763 19,763 - - Series B Preferred Stock
Joshua Lehrer-Graiwer Director, PRESIDENT AND CEO 13 Jan 2021 19,763 0 - - Series B Preferred Stock
Joshua Lehrer-Graiwer Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 13 Jan 2021 374,013 1,153,544 - 0.3 112,204 Common Stock
Joshua Lehrer-Graiwer Director, PRESIDENT AND CEO 13 Jan 2021 8,126 1,161,670 - - Common Stock
Katherine Vega Stultz CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 19,763 19,763 - - Series B Preferred Stock
Katherine Vega Stultz CHIEF OPERATING OFFICER 13 Jan 2021 8,126 216,020 - - Common Stock
Katherine Vega Stultz CHIEF OPERATING OFFICER 13 Jan 2021 19,763 0 - - Series B Preferred Stock
Katherine Vega Stultz CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 89,934 89,934 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters